Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Conscious Cogn ; 96: 103219, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34749157

RESUMEN

Research on the sense of agency has proliferated a range of explicit and implicit measures. However, the relation of different measures is poorly understood with especially mixed findings on the correlation between explicit judgments of agency and the implicit perceptual bias of temporal binding. Here, we add to the conundrum by showing that the two sub-components of temporal binding - action-binding and effect-binding, respectively - are not correlated across participants either, suggesting independent processes for both components. Research on inter-individual differences regarding the sense of agency is thus well-advised to rely on other implicit measures until the phenomenon of temporal binding is better understood.


Asunto(s)
Individualidad , Juicio , Humanos
2.
Neurology ; 76(1): 94-9, 2011 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-21205698

RESUMEN

OBJECTIVE: Epilepsy is a common neurologic condition with significant personal, societal, medical, and economic burdens. There are considerable gaps in the quality of care delivered. Measuring the quality of care delivered is the first step to its improvement. Performance measures are easily identified and quantitated ways to assess whether specific activities were carried out during a patient encounter. Therefore, epilepsy performance measures were derived through a standardized systematic process and may be the basis for pay-for-performance initiatives and maintenance of certification requirements. METHODS: Epilepsy measures were developed through the American Medical Association-convened Physician Consortium for Performance Improvement (PCPI) independent measure development process, which marked the first time a medical specialty society followed this process. Guidelines, measures, and consensus papers reviewed for the period 1998 to 2008 using the National Guidelines Clearinghouse, the National Quality Measures Clearinghouse, PubMed, MEDLINE, and the Cochrane Library were evaluated using a framework to determine the acceptability of each guideline or other evidence review document for measures development. Recommendation statements based on level of evidence, importance, validity, and gap in care were developed into candidate measures. A panel of experts from representative organizations vetted the measures. A period of public comment was followed by approval from the American Academy of Neurology and the PCPI. RESULTS: Literature search identified 160 relevant recommendation statements from 19 guidelines and 2 consensus papers. Systematic assessment resulted in 20 recommendation statements that were refined to 8 candidate measures by the expert panel. The measures are relevant to seizure type and frequency, etiology or epilepsy syndrome, EEG, neuroimaging, antiepileptic drug side effects, safety issues, referral for refractory epilepsy, and issues for women of childbearing potential. CONCLUSION: There is a reasonable evidence base, and consensus for, deriving performance measures for quality of epilepsy care. It is anticipated that implementation of these performance measures will improve care for patients with epilepsy if adopted by providers.


Asunto(s)
Academias e Institutos/organización & administración , Epilepsia/terapia , Neurología/normas , Mejoramiento de la Calidad/normas , Calidad de la Atención de Salud/normas , Academias e Institutos/normas , Academias e Institutos/estadística & datos numéricos , Bases de Datos Factuales/estadística & datos numéricos , Electroencefalografía , Epilepsia/diagnóstico , Medicina Basada en la Evidencia , Humanos , Guías de Práctica Clínica como Asunto , Estados Unidos
3.
Neurology ; 75(22): 2021-7, 2010 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-21115958

RESUMEN

BACKGROUND: Measuring the quality of health care is a fundamental step toward improving health care and is increasingly used in pay-for-performance initiatives and maintenance of certification requirements. Measure development to date has focused on primary care and common conditions such as diabetes; thus, the number of measures that apply to neurologic care is limited. The American Academy of Neurology (AAN) identified the need for neurologists to develop measures of neurologic care and to establish a process to accomplish this. OBJECTIVE: To adapt and test the feasibility of a process for independent development by the AAN of measures for neurologic conditions for national measurement programs. METHODS: A process that has been used nationally for measure development was adapted for use by the AAN. Topics for measure development are chosen based upon national priorities, available evidence base from a systematic literature search, gaps in care, and the potential impact for quality improvement. A panel composed of subject matter and measure development methodology experts oversees the development of the measures. Recommendation statements and their corresponding level of evidence are reviewed and considered for development into draft candidate measures. The candidate measures are refined by the expert panel during a 30-day public comment period and by review by the American Medical Association for Current Procedural Terminology (CPT) II codes. All final AAN measures are approved by the AAN Board of Directors. RESULTS: Parkinson disease (PD) was chosen for measure development. A review of the medical literature identified 258 relevant recommendation statements. A 28-member panel approved 10 quality measures for PD that included full specifications and CPT II codes. CONCLUSION: The AAN has adapted a measure development process that is suitable for national measurement programs and has demonstrated its capability to independently develop quality measures.


Asunto(s)
Neurología/normas , Enfermedad de Parkinson/terapia , Mejoramiento de la Calidad/normas , Calidad de la Atención de Salud/normas , Humanos
5.
Neurology ; 60(9): 1452-6, 2003 May 13.
Artículo en Inglés | MEDLINE | ID: mdl-12743230

RESUMEN

OBJECTIVES: To survey US physicians involved in acute stroke care to determine the proportion of hospitals that currently meet the recommended Brain Attack Coalition (BAC) criteria for Primary Stroke Centers (PSC) and obtain opinions regarding the value of stroke centers. METHODS: A survey regarding the BAC guidelines for the establishment of stroke centers was mailed to 3,245 US neurologists, neurosurgeons, and emergency physicians. RESULTS: A total of 1,032 responses were received. Seventy-nine percent (range by specialty 58 to 98%) of respondents believed there was a need for stroke centers. If formal stroke center designation were established, 81% (range 72 to 90%) would like their hospital to become a PSC. Although 77% of respondents believed that their hospital currently met recommended criteria for a PSC, only 7% actually meet all recommended elements. However, 44% of hospitals already provide most acute stroke services. The BAC criteria most frequently lacking were continuing medical education for professional stroke center staff, stroke training for emergency department staff, formal establishment of a stroke unit, and designation of a stroke center director. CONCLUSIONS: The majority of emergency medicine and neuroscience physician respondents involved in acute stroke care support the designation of primary stroke centers. Although respondents globally overestimated the extent to which their facilities currently meet BAC recommended criteria for PSC, detailed responses suggested that over 40% of hospitals possess substantial existing acute stroke care resources and are poised to function as PSC with modest additional administrative and financial commitment.


Asunto(s)
Actitud del Personal de Salud , Departamentos de Hospitales , Hospitales Especializados , Médicos/psicología , Accidente Cerebrovascular , Adulto , Ensayos Clínicos como Asunto , Medicina de Emergencia , Capacidad de Camas en Hospitales , Departamentos de Hospitales/normas , Hospitales Especializados/normas , Humanos , Neurología , Neurocirugia , Guías de Práctica Clínica como Asunto , Práctica Profesional/estadística & datos numéricos , Accidente Cerebrovascular/terapia
6.
J Anim Sci ; 61(2): 287-96, 1985 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-4044426

RESUMEN

Individual and group-reared boars were compared in two experiments, for treatment effects on mating behavior, growth rate, feed consumption and feed/gain. Soundness also was evaluated in one experiment. Boar-to-boar behaviors were studied in group-penned boars. In Exp. 1, boars were either reared in a group of five or individually from 12 to 27 wk of age, or group-penned from 12 to 19 wk and individually from 1-9 wk. In Exp. 2, boars were either penned individually from 6 to 27 wk, group-penned (eight/pen) from 6 to 27 wk, grouped from 6 to 12 wk and then penned individually, or individually penned from 6 to 12 wk and then group-penned. Beginning at 29 wk of age, boars were tested every 2 wk for mating behavior in the presence of an estrous gilt. Four mating tests were conducted in Exp. 1 and five tests in Exp. 2. Individually penned boars grew faster from 6 to 12 wk old in Exp. 2, but no other treatment effects on growth rate were observed. Treatment had very little effect on mating test behaviors, but individual penning markedly reduced leg soundness. Sheath sniffing first appeared at 16 to 18 wk of age in group-penned boars and was followed closely by anal sniffing. Side nosing increased between 20 and 23 wk. Mounting activity from 12 to 27 wk old was correlated with mating test score in Exp. 1 (.76; P less than .01) and Exp. 2 (.55; P less than .05).


Asunto(s)
Peso Corporal , Conducta Sexual Animal , Medio Social , Porcinos/fisiología , Animales , Cojera Animal/epidemiología , Masculino , Conducta Sexual Animal/fisiología , Olfato , Enfermedades de los Porcinos/epidemiología
9.
Biochemistry ; 16(5): 877-85, 1977 Mar 08.
Artículo en Inglés | MEDLINE | ID: mdl-402930

RESUMEN

An organic solvent soluble polypeptide has been isolated from photoreceptor complexes and chromatophores of Rhodospirillum rubrum. After extraction of the protein from lyophilized samples with 1:1 chloroform-methanol, it was purified by column chromatography. Its isoelectric point determined by isoelectric focusing was 7.10. When analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the purified polypeptide ran as a single band of an apparent molecular weight of 12 000. However, according to amino acid analysis, the minimal molecular weight based on one histidine residue per polypeptide is 19 000. The polypeptide contains no cysteine and no tyrosine. Amino acid analysis indicated that three methionines were present per histidine residue and cyanogen bromide cleavage gave four smaller peptides which were isolated by two-dimensional electrophoresis and chromatography. Spectroscopic analysis indicated the presence of three tryptophan residues per histidine and N-bromosuccinamide cleavage also gave four smaller peptides which could be isolated by two-dimensional electrophoresis and chromatography. The C-terminal amino acid was shown to be glycine by two methods, while the N-terminal amino acid appears to be blocked. The organic solvent soluble polypeptide accounts for approximately 50% of the chromatophore protein and seems to bind the antenna bacteriochlorophyll and carotenoid molecules. Using this procedure, organic solvent soluble polypeptides were isolated from several photosynthetic bacteria and were found to have substantially different amino acid contents.


Asunto(s)
Péptidos , Células Fotorreceptoras/fisiología , Rhodospirillum rubrum/fisiología , Aminoácidos/análisis , Cromatóforos Bacterianos/fisiología , Carboxipeptidasas , Electroforesis en Gel de Poliacrilamida , Peso Molecular , Fragmentos de Péptidos/análisis , Péptidos/aislamiento & purificación , Péptidos/fisiología , Dodecil Sulfato de Sodio , Solubilidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA